Ian Bouligny

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Virginia Commonwealth University(Current)

The University of Texas MD Anderson Cancer Center

Virginia Commonwealth University Medical Center

Ian Bouligny is an author at Virginia Commonwealth University specializing in acute myeloid leukemia treatment, medicine, and hematologic malignancy pharmacotherapy.

ORCID

Publications per year

2021–2025

Publications

Venetoclax with decitabine or azacitidine in the first‐line treatment of acute myeloid leukemia

Ian Bouligny, Graeme Murray, Michael Doyel et al. · eJHaem · 2023 · 18 citations · Full text

Medicine, Hematology, Pharmacology +14

Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia

Ian Bouligny, Graeme Murray, Michael Doyel et al. · Medical Oncology · 2024 · 12 citations

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of 10-day decitabine in acute myeloid leukemia

Ian Bouligny, Vivek Mehta, Scott Isom et al. · Leukemia Research · 2021 · 10 citations · Full text

Medicine, Oncology, Pharmacology +13

Oral decitabine cedazuridine with and without venetoclax in higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia: a propensity score–matched study

Álex Bataller, Koji Sasaki, Samuel Urrutia et al. · Blood Cancer Journal · 2025 · 10 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

1–4 of 4